Commercial Online Social Network Data and Statin Side-Effect Surveillance: A Pilot Observational Study of Aggregate Mentions on Facebook
ConclusionsFuture work on pharmacovigilance may be informed by this novel commercial tool, but the inability to mine the full text of a posting poses serious challenges to content categorization.
Source: Drug Safety - Category: Drugs & Pharmacology Source Type: research
More News: Cholesterol | Drugs & Pharmacology | Electronic Medical Records (EMR) | Internet | Men | Statin Therapy | Study